🇺🇸 FDA
Pipeline program

UB-421(25 mg/kg) Q2W

UBP-A218-HIV

Phase 2 mab active

Quick answer

UB-421(25 mg/kg) Q2W for HIV-1-infection is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
HIV-1-infection
Phase
Phase 2
Modality
mab
Status
active

Clinical trials